Xmrv/mlv virus

Maribel Arias and Hung Fan. Author information Article notes Copyright and License information Disclaimer. This article has been corrected. See Emerg Microbes Infect.

This article has been cited by other articles in PMC. Abstract Xenotropic murine leukemia virus-related virus XMRV was discovered in in a search for a viral etiology of human prostate cancer PC. Keywords: chronic fatigue syndrome, endogenous retrovirus, murine leukemia virus, prostate cancer, retrovirus, XMRV. Open in a separate window. Xpr-1 from non-murine species binds both xenotropic and polytropic Env.

Figure 1. References Rous P. A Sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med. Experiment elle leukamie be huhern. Zentralbl Bakteriol. Some possible effects of nursing on the mammary gland tumor incidence in mice. Development and serial cellfree passage of a highly potent strain of mouse leukemia virus.

Proc Soc Exp Biol Med. Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice. Note on a new inbred mouse-strain GR-A.

Eur J Cancer. An avian leukosis virus related to RSV O : properties and evidence for helper activity. Fields virology 6th ed. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer. Cancer Res. Human endogenous retroviruses and cancer: causality and therapeutic possibilities. World J Gastroenterol. Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer.

Semin Cancer Biol. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol. Retrovirus-induced de novo methylation of flanking host sequences correlates with gene inactivity. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.

J Virol. A new class of murine leukemia virus associated with development of spontaneous lymphomas. C-type virus particles in human tumours transplanted into nude mice. Br J Cancer. A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum.

Murine type C retroviruses and intracisternal A-particles in human tumors serially passaged in nude mice. J Natl Cancer Inst. Nat Genet. PLoS Pathog. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Analysis of single-nucleotide polymorphisms in patient-derived retrovirus integration sites reveals contamination from cell lines acutely infected by xenotropic murine leukemia virus-related virus.

Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.

Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. Multiple integrated copies and high-level production of the human retrovirus XMRV xenotropic murine leukemia virus-related virus from 22Rv1 prostate carcinoma cells.

No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients. Med Microbiol Immunol. Lack of evidence for xenotropic murine leukemia virus-related virus XMRV in German prostate cancer patients.

No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors.

Xenotropic murine leukemia virus-related virus is not associated with chronic fatigue syndrome in patients from different areas of the US in the s. Virol J. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome.

Failure to detect xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Adv Virol. Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses. Epub Oct 8. Etiology of fibromyalgia: the possible role of infection and vaccination. Autoimmun Rev. Are chronic fatigue syndrome and fibromyalgia the same?

Implications for the provision of appropriate mental health intervention. J Psychiatr Ment Health Nurs. Related Links More Letter Articles. Articles by Country Search — Search articles by the topic country. Article Type Search — Search articles by article type and issue.

Comments character s remaining. Comment submitted successfully, thank you for your feedback. There was an unexpected error. Message not sent. Page created: July 13, The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.

Use of trade names is for identification only and does not imply endorsement by any of the groups named above. Links with this icon indicate that you are leaving the CDC website. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. You will be subject to the destination website's privacy policy when you follow the link.

CDC is not responsible for Section compliance accessibility on other federal or private website. Cancel Continue. The trouble with this conspiracy theory is that not only is it demonstrably untrue, much of it derives from a scientific fraud that Mikovits and coworkers perpetrated in So, to understand how this took place, we need to give the uninitiated reader a little bit of background on retroviruses.

When a retrovirus infects an animal cell, the viral RNA is converted into DNA and then inserted directly into the genome of the cell. It will also be passed on to daughter cells should that infected cell divide. Acting essentially like a cellular gene, the virus then makes copies of its RNA genome and packages them into new virus particles that go on to infect the next cell.

A curious feature of retroviruses results from their lifestyle. On rare occasions, a retrovirus will infect a germ cell, that is, one that becomes either an egg or a sperm cell.

That means that when that cell forms a new organism, the retrovirus will be a part of the genome of every cell in the body and all generations from then on. Until , there were four retroviruses known to cause human disease. Then an article was published by Bob Silverman and coworkers in Ohio and Seattle.

They had been using a new technology to identify novel viruses in prostate cancer, and they had got a hit. In a couple of biopsies, and crucially in a long-established human prostate cancer cell line known as 22RV1, they identified a new retrovirus that was highly similar to mouse viruses that cause leukemia.

Although there was some concern about these data, XMRV had some attributes that made it attractive. And finally, promoter sequences at the left-hand end of the viral genome that are important for directing the production of new viral RNA genomes in infected cells contained elements that would be specifically activated by male hormones—perfect for viral replication in the prostate.

So much so in fact that when the Silverman laboratory cloned the virus as a DNA form, they replaced these sequences with those that allowed XMRV to replicate in any cell type—sequences known as a cytomegalovirus CMV promoter.

Judy Mikovits had worked on human retroviruses at the National Cancer Institute throughout the late s and early s with her mentor, Frank Ruscetti. After changing fields and moving into the private sector, Mikovits became the scientific director of a small private research institute, the Whittemore Peterson Institute WPI , in Reno, Nevada.

It lacked a robust case definition, its symptoms varied widely but could be incredibly debilitating, often associated with mental health problems. The story broke in in a now infamous article authored by Mikovits's team and published in Science. Even more surprising data followed. If true, the implications of this study were huge. Second, picking up 2 positives in 50 healthy controls, if extrapolated to the U.

What else might XMRV cause? However, many retrovirologists had been here before. XMRV was highly similar to endogenous retroviruses found in mice and other mammals, and with the amount of mouse DNA kicking around many laboratories, the sensitive tests that detected the presence of XMRV DNA in samples were prone to contamination.

To do this is very easy: one orders a set of fairly cheap reagents from a company and within 2—3 days you have the tools to test samples.

Any decent molecular biology laboratory can do this. Laboratories struggled with precisely the same issues now discussed on the news regarding SARS-CoV2 testing, with the key being to demonstrate that the test is sensitive enough to detect very low number of copies of the virus while avoiding false positives.

Once that is done, you are away, and the wheels started to come off of the XMRV bandwagon almost immediately. The study was rapidly published, and there was an immediate backlash. Mikovits claimed that the study was not a true replication study and was, therefore, invalid.

Myra McClure, even received death threats. Further U. She and her colleague Vincent Lombardi posted rebuttals on the WPI website every time a new one came out. Then an article from Harvey Alter, a clinician who first recognized hepatitis C, found evidence of murine leukemia virus-like sequences in both CFS and healthy blood samples.

But there was an issue. To detect the signal, Alter's colleagues had amplified the viral DNA vastly more than is normal in a diagnostic test, greatly increasing the risk of picking up a contaminant. Despite this, Mikovits hailed the article as a validation of her study.

There was something strange about the Alter study, first noticed by Stephane Hue in Prof. Greg Towers' group at University College London. They make mistakes, or mutations, in the sequence. This is a hallmark of retrovirus replication—so much so that a lack of sequence diversity means the virus is not actually replicating.

In fact, these sequences were identical to one of the 22RV1 viruses. This was very compelling evidence that not only could not XMRV be replicating in these people, it was very likely to be a laboratory contamination from the 22RV1 cell line.

In their excitement to publish this, they at first failed to notice another damning issue. The integration sites—the sequence of the human DNA either side of the virus—were identical to integration sites sequenced from experimentally infected cells in the same laboratory.